Rasio cepet: TransMedics Group Inc (TMDX)

TransMedics Group (TMDX) dominates tissue perfusion thanks to the OCS system. The assessment of short-term solvency excluding inventories confirms this potential, where 6.34 is the current level of the indicator. Stable demand for equipment makes the asset a safe haven during crises. Risks are minimal and relate only to plastic waste disposal, which does not affect the financial stability of the company.

Quick liquidity excludes illiquid inventories, assessing the company's ability to instantaneously settle obligations using cash and accounts receivable. For TransMedics Group (TMDX), whose OCS systems are critical for transplantology, monitoring quick liquidity confirms financial stability amid steady clinic demand, eliminating the dependence of solvency on warehouse inventory levels.